Immune response and lack of immune response to Plasmodium falciparum P126 antigen and its amino-terminal repeat in malaria-infected humans. 1998

D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
Department of Immunology, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.

A parasitophorous vacuole protein of Plasmodium falciparum, p126, is a potential candidate for a malaria vaccine. Its N-terminal region, composed of six repeats of eight amino acids, appears to be involved in the induction of protective immunity against P. falciparum challenge in monkeys. This study evaluated the immune response to p126 and to its N-terminal region (Nt47) in patients (n = 45) living in a malaria-endemic area of Brazil (Colina, Porto Velho, Rondonia). Cellular proliferative responses against Nt47 were low and infrequent. The study of the humoral immune response demonstrated that 95% of the patients had detectable anti-p126 antibodies and 77% had anti-Nt47 antibodies. Analysis of the antibody isotypes specific for Nt47 revealed that all four IgG subclasses were present and individuals with higher levels of anti-Nt47 cytophilic IgG antibody (IgG1 + IgG3/IgG2 + IgG4) had significantly lower parasitemia levels, suggesting that antibodies to the N-terminal region of the p126 protein may contribute to acquisition of immunity to P. falciparum malaria.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
March 1994, Clinical and experimental immunology,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
September 1993, Infection and immunity,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
August 2002, The Lancet. Infectious diseases,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
July 1992, Molecular and biochemical parasitology,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
December 1988, Molecular biology & medicine,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
June 2003, Parasitology international,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
November 1990, The American journal of tropical medicine and hygiene,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
January 1986, The American journal of tropical medicine and hygiene,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
June 1997, Molecular and biochemical parasitology,
D M Banic, and J de Oliveira-Ferreira, and L R Pratt-Riccio, and V Conseil, and D Gonçalves, and R R Fialho, and H Gras-Masse, and C T Daniel-Ribeiro, and D Camus
January 2000, Vaccine,
Copied contents to your clipboard!